idiopathicthrombocytopenicpurpuratreatment

2023年7月20日—Theguidelinessuggesteitherprednisone(0.5-2.0mg/kgperday)ordexamethasone(40mgperdayfor4days)asthetypeofcorticosteroidfor ...,2023年8月24日—What'sthetreatmentforimmunethrombocytopenia?;Corticosteroidstotemporarilyblocktheantibodiesthatdestroyplatelets.,Idiopathicthrombocytopenicpurpura(ITP)isarareautoimmunedisorderin...TreatmentforITP.TreatmentforITPincludestimeandcloseobservation....

Immune Thrombocytopenia (ITP) Treatment & Management

2023年7月20日 — The guidelines suggest either prednisone (0.5-2.0 mg/kg per day) or dexamethasone (40 mg per day for 4 days) as the type of corticosteroid for ...

Immune Thrombocytopenia (ITP)

2023年8月24日 — What's the treatment for immune thrombocytopenia? ; Corticosteroids to temporarily block the antibodies that destroy platelets.

Immune thrombocytopenic purpura (ITP)

Idiopathic thrombocytopenic purpura (ITP) is a rare autoimmune disorder in ... Treatment for ITP. Treatment for ITP includes time and close observation. If ...

Idiopathic Thrombocytopenic Purpura (ITP)

Although there is no known cause of ITP and there is no cure, the prognosis for a child with ITP is very good. Usually, the body stops making the antibodies ...

Immune thrombocytopenia (ITP)

2023年6月8日 — Once known as idiopathic thrombocytopenic purpura, ITP can cause purple bruises. It also can cause tiny reddish-purple dots on the skin that ...

Immune thrombocytopenia (ITP)

2023年6月8日 — Steroids. Health care providers often use an oral corticosteroid, such as prednisone. When the platelet count is back to a safe level, the ...

ITP-Immune Thrombocytopenic Purpura

由 AAJ Vaillant 著作 · 2022 · 被引用 29 次 — Therefore, splenectomy is the treatment of choice for adult patients with ITP who have persistent symptomatic thrombocytopenia. It is recommended that patients ...

Management of Immune Thrombocytopenic Purpura

由 R Warrier 著作 · 2012 · 被引用 45 次 — Treatment of ITP can be divided into medical and surgical management. Medical management is further divided into first-line and second-line pharmacotherapy.